BMJ Publishing Group, Journal of Clinical Pathology, 6(55), p. 461-466
DOI: 10.1136/jcp.55.6.461
Full text: Download
Aim: Several studies have investigated the expression of the cytokeratins (CKs), vimentin, the epithelial growth factor receptor (EGFR), the oestrogen receptor (ER), and the progesterone receptor (PgR), in breast cancer, but no study has directly compared p53 mutations with these phenotypic and differentiation markers in the same case. The present study was designed to provide some of this information.